JANE STREET GROUP, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$35,875
-5.1%
50,000
-3.5%
0.00%
Q2 2023$37,816
+13.4%
51,803
-6.8%
0.00%
Q1 2023$33,348
+50.5%
55,580
-1.5%
0.00%
Q4 2022$22,157
-64.8%
56,436
-0.2%
0.00%
Q3 2022$63,000
+26.0%
56,541
+0.2%
0.00%
Q2 2022$50,000
-54.5%
56,444
+0.4%
0.00%
Q1 2022$110,000
-15.4%
56,244
-1.1%
0.00%
Q4 2021$130,000
-13.9%
56,844
+8.7%
0.00%
Q3 2021$151,00052,2820.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 15,830$36,0000.11%
CVI Holdings, LLC 291,832$665,0000.04%
Sio Capital Management, LLC 49,998$114,0000.03%
Exos Asset Management LLC 27,151$62,0000.03%
Ionic Capital Management LLC 100,389$229,0000.03%
Alpine Global Management, LLC 47,500$108,0000.02%
TUDOR INVESTMENT CORP ET AL 236,549$539,0000.01%
LMR Partners LLP 50,000$363,0000.00%
Diameter Capital Partners LP 23,857$54,0000.00%
Virtu Financial LLC 10,314$24,0000.00%
View complete list of HUMACYTE INC shareholders